What is TTRX's EBITDA?

TTRX (TTRX) reported EBITDA of -$2.18M in Q4 2025.

How has TTRX's EBITDA changed year-over-year?

TTRX's EBITDA decreased by 587.6% year-over-year, from -$317.09K to -$2.18M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

TTRX TTRX EBITDA

EBITDA at other companies

Bausch Health CompaniesBHC

-$655M-213%

Journey Medical CorporationDERM

-$366K+83.8%

PTH

Pelthos Therapeutics Inc.PTHS

-$11.59M-532%

Celldex TherapeuticsCLDX

-$83.58M-35.1%

Arcutis Biotherapeutics, Inc.ARQT

-$8.53M+60.1%

Regeneron PharmaceuticalsREGN

——

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Calculated from TTRX’s reported figures.

−$2.2Mebit+

$13.2KDepreciation Depletion & Amortization

=-$2.18M

The official record: TTRX’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's EBITDA?: TTRX (TTRX) reported EBITDA of -$2.18M in Q4 2025.
How has TTRX's EBITDA changed year-over-year?: TTRX's EBITDA decreased by 587.6% year-over-year, from -$317.09K to -$2.18M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.